Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 38 | 2020 | 1577 | 2.560 |
Why?
|
| Urinary Bladder Neoplasms | 10 | 2021 | 541 | 1.830 |
Why?
|
| Quality of Life | 24 | 2021 | 2161 | 1.490 |
Why?
|
| Sexual and Gender Minorities | 5 | 2021 | 72 | 1.460 |
Why?
|
| Erectile Dysfunction | 9 | 2016 | 211 | 1.250 |
Why?
|
| Homosexuality, Male | 6 | 2021 | 72 | 1.180 |
Why?
|
| United States Department of Veterans Affairs | 3 | 2018 | 694 | 0.880 |
Why?
|
| Sexual Dysfunction, Physiological | 5 | 2016 | 92 | 0.850 |
Why?
|
| Patient Education as Topic | 7 | 2016 | 462 | 0.820 |
Why?
|
| Health Personnel | 3 | 2020 | 545 | 0.800 |
Why?
|
| Sexual Partners | 5 | 2016 | 85 | 0.750 |
Why?
|
| Health Status | 6 | 2016 | 408 | 0.700 |
Why?
|
| Cancer Survivors | 2 | 2020 | 250 | 0.650 |
Why?
|
| Survivorship | 1 | 2020 | 44 | 0.650 |
Why?
|
| Nurses | 1 | 2021 | 74 | 0.650 |
Why?
|
| Bisexuality | 3 | 2016 | 13 | 0.640 |
Why?
|
| Prostatectomy | 14 | 2016 | 358 | 0.640 |
Why?
|
| Patient Care Planning | 1 | 2020 | 130 | 0.610 |
Why?
|
| Internship, Nonmedical | 1 | 2018 | 1 | 0.600 |
Why?
|
| Sexual Dysfunctions, Psychological | 4 | 2013 | 46 | 0.570 |
Why?
|
| Watchful Waiting | 3 | 2015 | 77 | 0.550 |
Why?
|
| Physician Assistants | 1 | 2018 | 78 | 0.540 |
Why?
|
| Suburban Population | 1 | 2017 | 5 | 0.540 |
Why?
|
| Health Facilities | 1 | 2018 | 69 | 0.540 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 482 | 0.510 |
Why?
|
| Anxiety | 7 | 2018 | 1001 | 0.500 |
Why?
|
| Veterans | 6 | 2018 | 1763 | 0.500 |
Why?
|
| Interpersonal Relations | 7 | 2018 | 233 | 0.490 |
Why?
|
| Resistance Training | 3 | 2025 | 32 | 0.490 |
Why?
|
| Muscle Strength | 3 | 2025 | 86 | 0.480 |
Why?
|
| Primary Health Care | 3 | 2018 | 801 | 0.470 |
Why?
|
| Urban Population | 1 | 2017 | 245 | 0.470 |
Why?
|
| Rural Population | 1 | 2017 | 243 | 0.450 |
Why?
|
| Male | 67 | 2025 | 65014 | 0.450 |
Why?
|
| Sexology | 1 | 2014 | 5 | 0.440 |
Why?
|
| Muscle, Skeletal | 3 | 2025 | 1037 | 0.420 |
Why?
|
| Middle Aged | 41 | 2020 | 29021 | 0.420 |
Why?
|
| Perception | 2 | 2012 | 236 | 0.410 |
Why?
|
| Cystectomy | 2 | 2016 | 165 | 0.390 |
Why?
|
| Culture | 1 | 2012 | 72 | 0.370 |
Why?
|
| Surveys and Questionnaires | 14 | 2018 | 3995 | 0.350 |
Why?
|
| Decision Making | 3 | 2011 | 699 | 0.350 |
Why?
|
| Aged | 36 | 2020 | 21482 | 0.340 |
Why?
|
| Health Surveys | 1 | 2012 | 260 | 0.340 |
Why?
|
| Humans | 74 | 2025 | 132247 | 0.340 |
Why?
|
| Urinary Diversion | 2 | 2016 | 44 | 0.320 |
Why?
|
| Social Support | 5 | 2016 | 386 | 0.300 |
Why?
|
| Health Behavior | 1 | 2012 | 398 | 0.300 |
Why?
|
| Needs Assessment | 2 | 2011 | 178 | 0.290 |
Why?
|
| Mental Disorders | 4 | 2012 | 893 | 0.280 |
Why?
|
| Neoplasm Recurrence, Local | 8 | 2007 | 1304 | 0.280 |
Why?
|
| Depression | 9 | 2018 | 1350 | 0.280 |
Why?
|
| Life Style | 3 | 2012 | 453 | 0.280 |
Why?
|
| Patient Admission | 1 | 2009 | 187 | 0.270 |
Why?
|
| Self Concept | 2 | 2016 | 164 | 0.260 |
Why?
|
| Neoplasm Staging | 6 | 2013 | 1365 | 0.250 |
Why?
|
| Isometric Contraction | 1 | 2025 | 24 | 0.230 |
Why?
|
| Quadriceps Muscle | 1 | 2025 | 17 | 0.230 |
Why?
|
| Athletic Performance | 1 | 2024 | 14 | 0.220 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 663 | 0.220 |
Why?
|
| Patient Discharge | 1 | 2009 | 511 | 0.220 |
Why?
|
| Prostate-Specific Antigen | 7 | 2008 | 271 | 0.220 |
Why?
|
| Sexual Behavior | 6 | 2021 | 250 | 0.210 |
Why?
|
| Impotence, Vasculogenic | 1 | 2003 | 9 | 0.200 |
Why?
|
| Adaptation, Psychological | 5 | 2016 | 455 | 0.200 |
Why?
|
| Mental Health | 1 | 2006 | 377 | 0.200 |
Why?
|
| Adult | 20 | 2025 | 31614 | 0.200 |
Why?
|
| Substance-Related Disorders | 2 | 2021 | 491 | 0.200 |
Why?
|
| Afghan Campaign 2001- | 2 | 2013 | 120 | 0.190 |
Why?
|
| Iraq War, 2003-2011 | 2 | 2013 | 128 | 0.190 |
Why?
|
| Patient Satisfaction | 4 | 2016 | 482 | 0.190 |
Why?
|
| Diabetes Mellitus | 3 | 2006 | 926 | 0.180 |
Why?
|
| Fear | 3 | 2015 | 205 | 0.180 |
Why?
|
| Insurance Coverage | 3 | 2008 | 127 | 0.180 |
Why?
|
| Self-Help Groups | 2 | 2013 | 16 | 0.180 |
Why?
|
| Severity of Illness Index | 2 | 2006 | 3093 | 0.180 |
Why?
|
| United States | 11 | 2018 | 11669 | 0.170 |
Why?
|
| Health Care Surveys | 2 | 2020 | 295 | 0.170 |
Why?
|
| Social Workers | 1 | 2021 | 5 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 3358 | 0.170 |
Why?
|
| Sex Offenses | 1 | 2021 | 49 | 0.170 |
Why?
|
| Follow-Up Studies | 10 | 2014 | 5410 | 0.170 |
Why?
|
| Female | 17 | 2025 | 70787 | 0.170 |
Why?
|
| Registries | 9 | 2007 | 1591 | 0.160 |
Why?
|
| Risk-Taking | 2 | 2012 | 101 | 0.150 |
Why?
|
| Focus Groups | 1 | 2020 | 223 | 0.150 |
Why?
|
| Program Evaluation | 2 | 2018 | 456 | 0.150 |
Why?
|
| Counseling | 2 | 2011 | 233 | 0.150 |
Why?
|
| Survivors | 3 | 2016 | 358 | 0.140 |
Why?
|
| Cost of Illness | 2 | 2013 | 286 | 0.140 |
Why?
|
| Patient-Centered Care | 1 | 2021 | 237 | 0.140 |
Why?
|
| Health Services Needs and Demand | 2 | 2016 | 181 | 0.140 |
Why?
|
| Faculty | 1 | 2018 | 104 | 0.140 |
Why?
|
| Longitudinal Studies | 9 | 2007 | 1500 | 0.140 |
Why?
|
| Homosexuality | 2 | 2016 | 14 | 0.140 |
Why?
|
| Androgen Antagonists | 2 | 2010 | 133 | 0.140 |
Why?
|
| Body Mass Index | 3 | 2017 | 1700 | 0.140 |
Why?
|
| Personality Inventory | 2 | 2012 | 179 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2020 | 821 | 0.130 |
Why?
|
| Tobacco Use | 1 | 2017 | 32 | 0.130 |
Why?
|
| Neoplasms | 1 | 2012 | 2961 | 0.130 |
Why?
|
| Mentors | 1 | 2018 | 164 | 0.130 |
Why?
|
| Qualitative Research | 1 | 2020 | 662 | 0.130 |
Why?
|
| Reproducibility of Results | 6 | 2012 | 3018 | 0.130 |
Why?
|
| Uncertainty | 3 | 2015 | 104 | 0.130 |
Why?
|
| Patient Care Team | 1 | 2021 | 576 | 0.130 |
Why?
|
| Leadership | 1 | 2018 | 247 | 0.120 |
Why?
|
| Socioeconomic Factors | 4 | 2007 | 902 | 0.120 |
Why?
|
| Heterosexuality | 1 | 2016 | 8 | 0.120 |
Why?
|
| Travel | 1 | 2017 | 124 | 0.120 |
Why?
|
| Alcoholism | 1 | 2018 | 250 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2013 | 899 | 0.120 |
Why?
|
| Health Care Costs | 2 | 2011 | 415 | 0.120 |
Why?
|
| Psychometrics | 4 | 2012 | 693 | 0.120 |
Why?
|
| Veterans Health | 1 | 2017 | 179 | 0.120 |
Why?
|
| Object Attachment | 1 | 2015 | 55 | 0.110 |
Why?
|
| Cross-Sectional Studies | 5 | 2021 | 3761 | 0.110 |
Why?
|
| Time Factors | 6 | 2017 | 6451 | 0.110 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2016 | 186 | 0.110 |
Why?
|
| Cystoscopy | 1 | 2014 | 46 | 0.110 |
Why?
|
| Stress, Psychological | 3 | 2016 | 577 | 0.110 |
Why?
|
| Proportional Hazards Models | 6 | 2012 | 1461 | 0.110 |
Why?
|
| Internet | 1 | 2017 | 406 | 0.110 |
Why?
|
| Attitude to Health | 3 | 2012 | 261 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2012 | 1444 | 0.100 |
Why?
|
| Libido | 2 | 2010 | 37 | 0.100 |
Why?
|
| Disease Management | 2 | 2014 | 565 | 0.100 |
Why?
|
| Databases, Factual | 3 | 2007 | 1234 | 0.100 |
Why?
|
| Smoking Cessation | 1 | 2014 | 191 | 0.100 |
Why?
|
| Smoking | 2 | 2014 | 940 | 0.100 |
Why?
|
| Unsafe Sex | 1 | 2012 | 25 | 0.100 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2010 | 99 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2018 | 700 | 0.100 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2012 | 37 | 0.100 |
Why?
|
| Self Efficacy | 3 | 2015 | 209 | 0.090 |
Why?
|
| Cisplatin | 1 | 2013 | 282 | 0.090 |
Why?
|
| Epidemiologic Methods | 2 | 2010 | 99 | 0.090 |
Why?
|
| Ureteral Neoplasms | 1 | 2012 | 27 | 0.090 |
Why?
|
| Documentation | 1 | 2013 | 121 | 0.090 |
Why?
|
| Kidney Pelvis | 1 | 2012 | 47 | 0.090 |
Why?
|
| Hospitalization | 3 | 2009 | 1902 | 0.090 |
Why?
|
| Patient Compliance | 1 | 2014 | 473 | 0.090 |
Why?
|
| Clinical Competence | 1 | 2018 | 1078 | 0.090 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 674 | 0.090 |
Why?
|
| Health Promotion | 1 | 2014 | 399 | 0.090 |
Why?
|
| Disease-Free Survival | 4 | 2006 | 956 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2012 | 186 | 0.080 |
Why?
|
| Health Resources | 1 | 2011 | 135 | 0.080 |
Why?
|
| Young Adult | 5 | 2025 | 9966 | 0.080 |
Why?
|
| Penile Erection | 1 | 2010 | 86 | 0.080 |
Why?
|
| Mental Health Services | 2 | 2013 | 281 | 0.080 |
Why?
|
| HIV Infections | 3 | 2012 | 2049 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2012 | 855 | 0.080 |
Why?
|
| Health Policy | 2 | 2014 | 232 | 0.080 |
Why?
|
| Sexuality | 1 | 2009 | 13 | 0.080 |
Why?
|
| Case Management | 1 | 2009 | 19 | 0.080 |
Why?
|
| Medication Adherence | 1 | 2012 | 326 | 0.080 |
Why?
|
| Private Sector | 1 | 2009 | 26 | 0.070 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 734 | 0.070 |
Why?
|
| Family | 1 | 2012 | 595 | 0.070 |
Why?
|
| Psychology | 1 | 2009 | 58 | 0.070 |
Why?
|
| Age Factors | 5 | 2016 | 2923 | 0.070 |
Why?
|
| Group Processes | 1 | 2009 | 52 | 0.070 |
Why?
|
| Adenocarcinoma | 2 | 2006 | 1018 | 0.070 |
Why?
|
| Treatment Outcome | 6 | 2013 | 13027 | 0.070 |
Why?
|
| Prospective Studies | 4 | 2015 | 6568 | 0.070 |
Why?
|
| Models, Psychological | 1 | 2009 | 144 | 0.070 |
Why?
|
| Goals | 1 | 2009 | 134 | 0.070 |
Why?
|
| Prognosis | 5 | 2013 | 5016 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2012 | 451 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2009 | 143 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2008 | 144 | 0.070 |
Why?
|
| Coitus | 1 | 2006 | 21 | 0.060 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2006 | 37 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2009 | 416 | 0.060 |
Why?
|
| Aged, 80 and over | 6 | 2016 | 7138 | 0.060 |
Why?
|
| Sex Factors | 3 | 2016 | 1354 | 0.060 |
Why?
|
| Orchiectomy | 1 | 2006 | 54 | 0.060 |
Why?
|
| North America | 1 | 2006 | 265 | 0.060 |
Why?
|
| Sexually Transmitted Diseases | 3 | 2013 | 95 | 0.060 |
Why?
|
| Lymph Node Excision | 1 | 2006 | 174 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2009 | 311 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2006 | 167 | 0.060 |
Why?
|
| Psychiatry | 1 | 2009 | 272 | 0.060 |
Why?
|
| Complementary Therapies | 1 | 2005 | 42 | 0.060 |
Why?
|
| Primary Prevention | 1 | 2006 | 179 | 0.060 |
Why?
|
| Prostate | 3 | 2020 | 437 | 0.060 |
Why?
|
| Cohort Studies | 5 | 2008 | 5176 | 0.060 |
Why?
|
| Health Services | 1 | 2005 | 71 | 0.060 |
Why?
|
| Electromyography | 1 | 2025 | 140 | 0.050 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2006 | 265 | 0.050 |
Why?
|
| Research Design | 1 | 2009 | 743 | 0.050 |
Why?
|
| Retrospective Studies | 5 | 2013 | 17395 | 0.050 |
Why?
|
| Obesity | 2 | 2006 | 2398 | 0.050 |
Why?
|
| Demography | 1 | 2005 | 242 | 0.050 |
Why?
|
| Spouses | 2 | 2016 | 73 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1829 | 0.050 |
Why?
|
| Risk Factors | 8 | 2015 | 10945 | 0.050 |
Why?
|
| Depressive Disorder, Major | 1 | 2009 | 453 | 0.050 |
Why?
|
| Social Values | 1 | 1993 | 48 | 0.050 |
Why?
|
| Length of Stay | 1 | 2009 | 1382 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 1307 | 0.050 |
Why?
|
| Regression Analysis | 3 | 2012 | 796 | 0.050 |
Why?
|
| Multivariate Analysis | 4 | 2008 | 1444 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1993 | 236 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2003 | 209 | 0.040 |
Why?
|
| Homeostasis | 1 | 2024 | 722 | 0.040 |
Why?
|
| Texas | 2 | 2021 | 3632 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2004 | 767 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2012 | 1008 | 0.030 |
Why?
|
| Disease Progression | 2 | 2015 | 2233 | 0.030 |
Why?
|
| Age Distribution | 1 | 2018 | 437 | 0.030 |
Why?
|
| Resilience, Psychological | 1 | 2018 | 80 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2013 | 3736 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2005 | 1683 | 0.030 |
Why?
|
| Social Class | 2 | 2008 | 207 | 0.030 |
Why?
|
| Muscle, Smooth | 1 | 2016 | 131 | 0.030 |
Why?
|
| Comorbidity | 2 | 2012 | 1610 | 0.030 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 396 | 0.030 |
Why?
|
| Self Care | 1 | 2016 | 227 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 665 | 0.030 |
Why?
|
| Survival Rate | 2 | 2012 | 2196 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 400 | 0.030 |
Why?
|
| California | 2 | 2005 | 140 | 0.030 |
Why?
|
| Health Education | 1 | 1996 | 235 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 2314 | 0.030 |
Why?
|
| Biopsy, Needle | 2 | 2005 | 234 | 0.020 |
Why?
|
| Child Abuse, Sexual | 1 | 2013 | 34 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1294 | 0.020 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2012 | 53 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2013 | 174 | 0.020 |
Why?
|
| Infertility | 1 | 2013 | 81 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2011 | 34 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 236 | 0.020 |
Why?
|
| Long-Term Care | 1 | 2011 | 72 | 0.020 |
Why?
|
| Emotions | 2 | 2005 | 367 | 0.020 |
Why?
|
| Violence | 1 | 2012 | 127 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2012 | 352 | 0.020 |
Why?
|
| Feminization | 1 | 2010 | 3 | 0.020 |
Why?
|
| Hospitals, Veterans | 1 | 2013 | 348 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2012 | 425 | 0.020 |
Why?
|
| SEER Program | 1 | 2012 | 220 | 0.020 |
Why?
|
| Canada | 1 | 2011 | 337 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 152 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 333 | 0.020 |
Why?
|
| Health Literacy | 1 | 2010 | 78 | 0.020 |
Why?
|
| Fatigue | 1 | 2010 | 201 | 0.020 |
Why?
|
| Informatics | 1 | 2009 | 8 | 0.020 |
Why?
|
| Medical Laboratory Science | 1 | 2009 | 13 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1128 | 0.020 |
Why?
|
| Parents | 1 | 1996 | 1080 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2013 | 1249 | 0.020 |
Why?
|
| Asthma | 1 | 1996 | 773 | 0.020 |
Why?
|
| Consensus | 1 | 2011 | 658 | 0.020 |
Why?
|
| Sleep Wake Disorders | 1 | 2010 | 197 | 0.020 |
Why?
|
| Inpatients | 1 | 2012 | 553 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1841 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 463 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 2139 | 0.020 |
Why?
|
| Income | 1 | 2008 | 140 | 0.020 |
Why?
|
| Radiotherapy | 1 | 2008 | 145 | 0.020 |
Why?
|
| Brachytherapy | 1 | 2008 | 95 | 0.020 |
Why?
|
| Sex Education | 1 | 2006 | 20 | 0.020 |
Why?
|
| Retreatment | 1 | 2007 | 93 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2007 | 166 | 0.020 |
Why?
|
| Diethylstilbestrol | 1 | 2006 | 45 | 0.020 |
Why?
|
| Finasteride | 1 | 2006 | 18 | 0.020 |
Why?
|
| Pelvis | 1 | 2006 | 74 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2007 | 588 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2006 | 77 | 0.020 |
Why?
|
| Educational Status | 1 | 2007 | 294 | 0.020 |
Why?
|
| Life Tables | 1 | 2005 | 28 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2012 | 651 | 0.010 |
Why?
|
| Health Maintenance Organizations | 1 | 2005 | 20 | 0.010 |
Why?
|
| Cognition | 1 | 2010 | 811 | 0.010 |
Why?
|
| Hospitals, University | 1 | 2005 | 105 | 0.010 |
Why?
|
| Urinary Tract | 1 | 2005 | 66 | 0.010 |
Why?
|
| Exercise | 1 | 2010 | 860 | 0.010 |
Why?
|
| Recurrence | 1 | 2008 | 1453 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3139 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 3376 | 0.010 |
Why?
|
| Ejaculation | 1 | 2003 | 22 | 0.010 |
Why?
|
| Sick Role | 1 | 2003 | 31 | 0.010 |
Why?
|
| Social Behavior | 1 | 2005 | 225 | 0.010 |
Why?
|
| Condoms | 1 | 1993 | 51 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 589 | 0.010 |
Why?
|
| Risk | 1 | 2005 | 761 | 0.010 |
Why?
|
| Data Collection | 1 | 2005 | 391 | 0.010 |
Why?
|
| AIDS Serodiagnosis | 1 | 1993 | 56 | 0.010 |
Why?
|
| Penile Prosthesis | 1 | 2003 | 41 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2005 | 429 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2006 | 778 | 0.010 |
Why?
|
| HIV Seropositivity | 1 | 1993 | 128 | 0.010 |
Why?
|
| Pain | 1 | 2005 | 462 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 322 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2007 | 697 | 0.010 |
Why?
|
| Age of Onset | 1 | 2003 | 626 | 0.010 |
Why?
|
| Intestines | 1 | 2005 | 606 | 0.010 |
Why?
|
| Adolescent | 2 | 2012 | 20557 | 0.010 |
Why?
|
| Child | 2 | 2013 | 25783 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1996 | 277 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 1996 | 230 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 34854 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1996 | 1255 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1996 | 14736 | 0.000 |
Why?
|